Delivery Order SPE2DB24D2205-SPE2DB25FEFSV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,905.12 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector units (two-pack configuration). This firm fixed-price delivery order is scheduled for ultimate completion on August 4, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation, with performance to be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,277.20 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This contract represents a firm fixed-price delivery order with a ceiling value of $3,057.33 and an ultimate completion date of August 15, 2025. The award was made through open competition with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.28 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by July 21, 2025. The order was issued on July 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,856.40 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector units (2-pack). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 9, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency awarded a $2,689.26 delivery order to AmerisourceBergen Drug Corp for the procurement of Epinephrine 0.3 mg auto-injector units (2-pack) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFSVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,545.04 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed price, competitively awarded delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract represents a non-set-aside procurement through open competition, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania headquarters location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The current award fulfills an immediate federal medical supply need for epinephrine auto-injectors, supporting DLA's mission to ensure medical readiness across Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/1/25 |